Cell and Gene Therapy Market Size, Share, Growth, and Industry Analysis, By Type (Rare Diseases, Oncology, Hematology, Cardiovascular, Ophthalmology, Neurology, Other Therapeutic Classes), By Application (Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Contract Research Organizations (CROs), Hospital, Others), and Regional Forecast to 2033

Last Updated: 14 July 2025
SKU ID: 28243827
ask for customization Buy Now
ask for customization Request a FREE Sample PDF

Detailed TOC of Global Cell and Gene Therapy Market Growth (Status and Outlook) 2033

1 Scope of the Report

    1. Market Introduction
    2. Years Considered
    3. Research Objectives
    4. Market Research Methodology
    5. Research Process and Data Source
    6. Economic Indicators
    7. Currency Considered
    8. Market Estimation Caveats
  2. Executive Summary
    1. World Market Overview
      1. Global Cell and Gene Therapy Market Size 2019-2033
      2. Cell and Gene Therapy Market Size CAGR by Region 2019 VS 2023 VS 2033
    2. Cell and Gene Therapy Segment by Type
      1. Rare Diseases
      2. Oncology
      3. Hematology
      4. Cardiovascular
      5. Ophthalmology
      6. Neurology
      7. Other Therapeutic Classes
    3. Cell and Gene Therapy Market Size by Type
      1. Cell and Gene Therapy Market Size CAGR by Type (2019 VS 2023 VS 2033)
      2. Global Cell and Gene Therapy Market Size Market Share by Type (2019-2024)
    4. Cell and Gene Therapy Segment by Application
      1. Pharmaceutical and Biotechnology Companies
      2. Research and Academic Institutions
      3. Contract Research Organizations (CROs)
      4. Hospital
      5. Others
    5. Cell and Gene Therapy Market Size by Application
      1. Cell and Gene Therapy Market Size CAGR by Application (2019 VS 2023 VS 2033)
      2. Global Cell and Gene Therapy Market Size Market Share by Application (2019-2024)
  3. Cell and Gene Therapy Market Size by Player
    1. Cell and Gene Therapy Market Size Market Share by Players
      1. Global Cell and Gene Therapy Revenue by Players (2019-2024)
      2. Global Cell and Gene Therapy Revenue Market Share by Players (2019-2024)
    2. Global Cell and Gene Therapy Key Players Head office and Products Offered
    3. Market Concentration Rate Analysis
      1. Competition Landscape Analysis
      2. Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    4. New Products and Potential Entrants
    5. Mergers & Acquisitions, Expansion
  4. Cell and Gene Therapy by Regions
    1. Cell and Gene Therapy Market Size by Regions (2019-2024)
    2. Americas Cell and Gene Therapy Market Size Growth (2019-2024)
    3. APAC Cell and Gene Therapy Market Size Growth (2019-2024)
    4. Europe Cell and Gene Therapy Market Size Growth (2019-2024)
    5. Middle East & Africa Cell and Gene Therapy Market Size Growth (2019-2024)
  5. Americas
    1. Americas Cell and Gene Therapy Market Size by Country (2019-2024)
    2. Americas Cell and Gene Therapy Market Size by Type (2019-2024)
    3. Americas Cell and Gene Therapy Market Size by Application (2019-2024)
    4. United States
    5. Canada
    6. Mexico
    7. Brazil
  6. APAC
    1. APAC Cell and Gene Therapy Market Size by Region (2019-2024)
    2. APAC Cell and Gene Therapy Market Size by Type (2019-2024)
    3. APAC Cell and Gene Therapy Market Size by Application (2019-2024)
    4. China
    5. Japan
    6. Korea
    7. Southeast Asia
    8. India
    9. Australia
  7. Europe
    1. Europe Cell and Gene Therapy by Country (2019-2024)
    2. Europe Cell and Gene Therapy Market Size by Type (2019-2024)
    3. Europe Cell and Gene Therapy Market Size by Application (2019-2024)
    4. Germany
    5. France
    6. UK
    7. Italy
    8. Russia
  8. Middle East & Africa
    1. Middle East & Africa Cell and Gene Therapy by Region (2019-2024)
    2. Middle East & Africa Cell and Gene Therapy Market Size by Type (2019-2024)
    3. Middle East & Africa Cell and Gene Therapy Market Size by Application (2019-2024)
    4. Egypt
    5. South Africa
    6. Israel
    7. Turkey
    8. GCC Countries
  9. Market Drivers, Challenges and Trends
    1. Market Drivers & Growth Opportunities
    2. Market Challenges & Risks
    3. Industry Trends
  10. Global Cell and Gene Therapy Market Forecast
    1. Global Cell and Gene Therapy Forecast by Regions (2025-2033)
      1. Global Cell and Gene Therapy Forecast by Regions (2025-2033)
      2. Americas Cell and Gene Therapy Forecast
      3. APAC Cell and Gene Therapy Forecast
      4. Europe Cell and Gene Therapy Forecast
      5. Middle East & Africa Cell and Gene Therapy Forecast
    2. Americas Cell and Gene Therapy Forecast by Country (2025-2033)
      1. United States Cell and Gene Therapy Market Forecast
      2. Canada Cell and Gene Therapy Market Forecast
      3. Mexico Cell and Gene Therapy Market Forecast
      4. Brazil Cell and Gene Therapy Market Forecast
    3. APAC Cell and Gene Therapy Forecast by Region (2025-2033)
      1. China Cell and Gene Therapy Market Forecast
      2. Japan Cell and Gene Therapy Market Forecast
      3. Korea Cell and Gene Therapy Market Forecast
      4. Southeast Asia Cell and Gene Therapy Market Forecast
      5. India Cell and Gene Therapy Market Forecast
      6. Australia Cell and Gene Therapy Market Forecast
    4. Europe Cell and Gene Therapy Forecast by Country (2025-2033)
      1. Germany Cell and Gene Therapy Market Forecast
      2. France Cell and Gene Therapy Market Forecast
      3. UK Cell and Gene Therapy Market Forecast
      4. Italy Cell and Gene Therapy Market Forecast
      5. Russia Cell and Gene Therapy Market Forecast
    5. Middle East & Africa Cell and Gene Therapy Forecast by Region (2025-2033)
      1. Egypt Cell and Gene Therapy Market Forecast
      2. South Africa Cell and Gene Therapy Market Forecast
      3. Israel Cell and Gene Therapy Market Forecast
      4. Turkey Cell and Gene Therapy Market Forecast
      5. GCC Countries Cell and Gene Therapy Market Forecast
    6. Global Cell and Gene Therapy Forecast by Type (2025-2033)
    7. Global Cell and Gene Therapy Forecast by Application (2025-2033)
  1. Key Players Analysis
    1. Amgen Inc.
      1. Amgen Inc. Company Information
      2. Amgen Inc. Cell and Gene Therapy Product Offered
      3. Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Amgen Inc. Main Business Overview
      5. Amgen Inc. Latest Developments
    2. bluebird bio, Inc.
      1. bluebird bio, Inc. Company Information
      2. bluebird bio, Inc. Cell and Gene Therapy Product Offered
      3. bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. bluebird bio, Inc. Main Business Overview
      5. bluebird bio, Inc. Latest Developments
    3. Dendreon Pharmaceuticals LLC.
      1. Dendreon Pharmaceuticals LLC. Company Information
      2. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
      3. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Dendreon Pharmaceuticals LLC. Main Business Overview
      5. Dendreon Pharmaceuticals LLC. Latest Developments
    4. Fibrocell Science, Inc.
      1. Fibrocell Science, Inc. Company Information
      2. Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
      3. Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Fibrocell Science, Inc. Main Business Overview
      5. Fibrocell Science, Inc. Latest Developments
    5. Human Stem Cells Institute
      1. Human Stem Cells Institute Company Information
      2. Human Stem Cells Institute Cell and Gene Therapy Product Offered
      3. Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Human Stem Cells Institute Main Business Overview
      5. Human Stem Cells Institute Latest Developments
    6. Kite Pharma, Inc.
      1. Kite Pharma, Inc. Company Information
      2. Kite Pharma, Inc. Cell and Gene Therapy Product Offered
      3. Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Kite Pharma, Inc. Main Business Overview
      5. Kite Pharma, Inc. Latest Developments
    7. Kolon TissueGene, Inc.
      1. Kolon TissueGene, Inc. Company Information
      2. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
      3. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Kolon TissueGene, Inc. Main Business Overview
      5. Kolon TissueGene, Inc. Latest Developments
    8. Novartis AG
      1. Novartis AG Company Information
      2. Novartis AG Cell and Gene Therapy Product Offered
      3. Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Novartis AG Main Business Overview
      5. Novartis AG Latest Developments
    9. Orchard Therapeutics plc.
      1. Orchard Therapeutics plc. Company Information
      2. Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
      3. Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Orchard Therapeutics plc. Main Business Overview
      5. Orchard Therapeutics plc. Latest Developments
    10. Organogenesis Holdings Inc.
      1. Organogenesis Holdings Inc. Company Information
      2. Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
      3. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Organogenesis Holdings Inc. Main Business Overview
      5. Organogenesis Holdings Inc. Latest Developments
    11. Pfizer, Inc.
      1. Pfizer, Inc. Company Information
      2. Pfizer, Inc. Cell and Gene Therapy Product Offered
      3. Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Pfizer, Inc. Main Business Overview
      5. Pfizer, Inc. Latest Developments
    12. RENOVA THERAPEUTICS
      1. RENOVA THERAPEUTICS Company Information
      2. RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered
      3. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. RENOVA THERAPEUTICS Main Business Overview
      5. RENOVA THERAPEUTICS Latest Developments
    13. Shanghai Sunway Biotech Co., Ltd.,
      1. Shanghai Sunway Biotech Co., Ltd., Company Information
      2. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered
      3. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Shanghai Sunway Biotech Co., Ltd., Main Business Overview
      5. Shanghai Sunway Biotech Co., Ltd., Latest Developments
    14. Sibiono GeneTech Co. Ltd.,
      1. Sibiono GeneTech Co. Ltd., Company Information
      2. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered
      3. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Sibiono GeneTech Co. Ltd., Main Business Overview
      5. Sibiono GeneTech Co. Ltd., Latest Developments
    15. Spark Therapeutics, Inc.
      1. Spark Therapeutics, Inc. Company Information
      2. Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered
      3. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Spark Therapeutics, Inc. Main Business Overview
      5. Spark Therapeutics, Inc. Latest Developments
    16. Vericel Corporation
      1. Vericel Corporation Company Information
      2. Vericel Corporation Cell and Gene Therapy Product Offered
      3. Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. Vericel Corporation Main Business Overview
      5. Vericel Corporation Latest Developments
    17. ViroMed Co., Ltd.
      1. ViroMed Co., Ltd. Company Information
      2. ViroMed Co., Ltd. Cell and Gene Therapy Product Offered
      3. ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
      4. ViroMed Co., Ltd. Main Business Overview
      5. ViroMed Co., Ltd. Latest Developments
  2. Research Findings and Conclusion